Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II.

Por Grosjean, P., Wagnieres, G., Fontolliet, C., van den Bergh, H., Monnier, P.
Publicado em 1998

7,12-Dimethylbenz[a]anthracene-induced ‘early’ squamous cell carcinoma in the Golden Syrian hamster: evaluation of an animal model and comparison with ‘early’ forms of human squamo...

Por ANDREJEVIC, S., SAVARY, J-F., FONTOLLIET, C., MONNIER, Ph., VAN DEN BERGH, H.
Publicado em 1996

Selectivity of the photosensitiser Tookad® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model

Por Borle, F, Radu, A, Fontolliet, C, van den Bergh, H, Monnier, P, Wagnières, G
Publicado em 2003

Uptake and localisation of mTHPC (Foscan®) and its(14)C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study

Por Blant, S Andrejevic, Glanzmann, T M, Ballini, J-P, Wagnières, G, van den Bergh, H, Monnier, P
Publicado em 2002

Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne(®)), in the CAM model

Por Debefve, E., Pegaz, B., van den Bergh, H., Wagnières, G., Lange, N., Ballini, J.-P.
Publicado em 2008

Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study

Por Lüdicke, F, Gabrecht, T, Lange, N, Wagnières, G, van den Bergh, H, Berclaz, L, Major, A L
Publicado em 2003

Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.

Por Andrejevic-Blant, S., Hadjur, C., Ballini, J. P., Wagnières, G., Fontolliet, C., van den Bergh, H., Monnier, P.
Publicado em 1997

Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers

Por Adar, Y, Stark, M, Bram, E E, Nowak-Sliwinska, P, van den Bergh, H, Szewczyk, G, Sarna, T, Skladanowski, A, Griffioen, A W, Assaraf, Y G
Publicado em 2012

Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition

Por Nowak-Sliwinska, P, Weiss, A, van Beijnum, J R, Wong, T J, Kilarski, W W, Szewczyk, G, Verheul, H M W, Sarna, T, van den Bergh, H, Griffioen, A W
Publicado no Cell Death Dis (2015)